Alzamend Neuro, Inc. (ALZN)
NASDAQ: ALZN · Real-Time Price · USD
2.490
+0.140 (5.96%)
At close: Aug 22, 2025, 4:00 PM
2.490
0.00 (0.00%)
After-hours: Aug 22, 2025, 4:24 PM EDT
Alzamend Neuro Market Cap
Alzamend Neuro has a market cap or net worth of $7.82 million as of August 22, 2025. Its market cap has increased by 305.84% in one year.
Market Cap
7.82M
Enterprise Value
3.40M
1-Year Change
305.84%
Ranking
Category
Stock Price
$2.49
Market Cap Chart
Since the IPO on June 15, 2021, Alzamend Neuro's market cap has decreased from $1.15B to $7.82M, a decrease of -99.32%. That is a compound annual growth rate of -69.62%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Aug 21, 2025 | 7.38M | 17.08% |
| Dec 31, 2024 | 6.30M | -0.56% |
| Dec 29, 2023 | 6.34M | -88.37% |
| Dec 30, 2022 | 54.47M | -67.73% |
| Dec 31, 2021 | 168.82M | -85.28% |
| Jun 15, 2021 | 1.15B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 637.23B |
| Johnson & Johnson | 430.92B |
| AbbVie | 370.09B |
| UnitedHealth Group | 274.74B |
| AstraZeneca | 250.88B |
| Novartis AG | 246.51B |
| Novo Nordisk | 246.31B |
| Abbott Laboratories | 229.74B |